Continuous infusion of vincristine, ifosfamide and epirubicin over 6 weeks in treatment-resistant advanced breast cancer
- 31 October 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (11) , 1773-1777
- https://doi.org/10.1016/0959-8049(95)00384-u
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Escalating drug delivery in cancer chemotherapy: A review of concepts and practice —Part 2Annals of Oncology, 1993
- Interaction of epirubicin with other cytotoxics and anti-emetic drugsAnti-Cancer Drugs, 1992
- High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report.Journal of Clinical Oncology, 1992
- Interrupted versus Continuous Chemotherapy in Patients with Metastatic Breast CancerNew England Journal of Medicine, 1991
- Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancerCancer, 1990
- Ifosfamide by continuous infusion to prevent encephalopathyThe Lancet, 1990
- Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancerBreast Cancer Research and Treatment, 1989
- Degradation kinetics of vincristine sulphate and vindesine sulphate in aqueous solutionsInternational Journal of Pharmaceutics, 1989
- A Comparative Study of Doxorubicin and Epirubicin in Patients with Metastatic Breast CancerAmerican Journal of Clinical Oncology, 1989
- The efficacy of combined chemotherapy and radiotherapy in advanced non-metastatic breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1988